Literature DB >> 23597352

Offender diversion into substance use disorder treatment: the economic impact of California's proposition 36.

M Douglas Anglin1, Bohdan Nosyk, Adi Jaffe, Darren Urada, Elizabeth Evans.   

Abstract

OBJECTIVES: We determined the costs and savings attributable to the California Substance Abuse and Crime Prevention Act (SACPA), which mandated probation or continued parole with substance abuse treatment in lieu of incarceration for adult offenders convicted of nonviolent drug offenses and probation and parole violators.
METHODS: We used individually linked, population-level administrative data to define intervention and control cohorts of offenders meeting SACPA eligibility criteria. Using multivariate difference-in-differences analysis, we estimated the effect of SACPA implementation on the total and domain-specific costs to state and county governments, controlling for fixed individual and county characteristics and changes in crime at the county level.
RESULTS: The additional costs of treatment were more than offset by savings in other domains, primarily in the costs of incarceration. We estimated the statewide policy effect as an adjusted savings of $2317 (95% confidence interval = $1905, $2730) per offender over a 30-month postconviction period. SACPA implementation resulted in greater incremental cost savings for Blacks and Hispanics, who had markedly higher rates of conviction and incarceration.
CONCLUSIONS: The monetary benefits to government exceeded the additional costs of SACPA implementation and provision of treatment.

Entities:  

Mesh:

Year:  2013        PMID: 23597352      PMCID: PMC3698729          DOI: 10.2105/AJPH.2012.301168

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  20 in total

1.  Drug court effectiveness: a review of California evaluation reports, 1995-1999.

Authors:  J Guydish; E Wolfe; B Tajima; W J Woods
Journal:  J Psychoactive Drugs       Date:  2001 Oct-Dec

2.  Benefits and costs of methadone treatment: results from a lifetime simulation model.

Authors:  Gary A Zarkin; Laura J Dunlap; Katherine A Hicks; Daniel Mamo
Journal:  Health Econ       Date:  2005-11       Impact factor: 3.046

3.  Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?

Authors:  Susan L Ettner; David Huang; Elizabeth Evans; Danielle Rose Ash; Mary Hardy; Mickel Jourabchi; Yih-Ing Hser
Journal:  Health Serv Res       Date:  2006-02       Impact factor: 3.402

Review 4.  Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol.

Authors:  Peter Anderson; Dan Chisholm; Daniela C Fuhr
Journal:  Lancet       Date:  2009-06-27       Impact factor: 79.321

5.  Cross-system data linkage for treatment outcome evaluation: lessons learned from the California Treatment Outcome Project.

Authors:  Yih-Ing Hser; Elizabeth Evans
Journal:  Eval Program Plann       Date:  2008-02-19

6.  Treatment entry barriers among California's Proposition 36 offenders.

Authors:  Elizabeth Evans; Libo Li; Yih-Ing Hser
Journal:  J Subst Abuse Treat       Date:  2008-06-02

7.  Drug use and crime: a historical review of research conducted by the UCLA Drug Abuse Research Center.

Authors:  M D Anglin; B Perrochet
Journal:  Subst Use Misuse       Date:  1998-07       Impact factor: 2.164

8.  Initiation of Primary Care-Mental Health Integration programs in the VA Health System: associations with psychiatric diagnoses in primary care.

Authors:  Kara Zivin; Paul N Pfeiffer; Benjamin R Szymanski; Marcia Valenstein; Edward P Post; Erin M Miller; John F McCarthy
Journal:  Med Care       Date:  2010-09       Impact factor: 2.983

Review 9.  Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.

Authors:  M Connock; A Juarez-Garcia; S Jowett; E Frew; Z Liu; R J Taylor; A Fry-Smith; E Day; N Lintzeris; T Roberts; A Burls; R S Taylor
Journal:  Health Technol Assess       Date:  2007-03       Impact factor: 4.014

10.  Has payment by results affected the way that English hospitals provide care? Difference-in-differences analysis.

Authors:  Shelley Farrar; Deokhee Yi; Matt Sutton; Martin Chalkley; Jon Sussex; Anthony Scott
Journal:  BMJ       Date:  2009-08-27
View more
  12 in total

1.  Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine.

Authors:  Noa Krawczyk; Caroline E Picher; Kenneth A Feder; Brendan Saloner
Journal:  Health Aff (Millwood)       Date:  2017-12       Impact factor: 6.301

2.  The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California.

Authors:  Emanuel Krebs; Darren Urada; Elizabeth Evans; David Huang; Yih-Ing Hser; Bohdan Nosyk
Journal:  Addiction       Date:  2017-02-06       Impact factor: 6.526

3.  Estimating State Transitions for Opioid Use Disorders.

Authors:  Emanuel Krebs; Jeong E Min; Elizabeth Evans; Libo Li; Lei Liu; David Huang; Darren Urada; Thomas Kerr; Yih-Ing Hser; Bohdan Nosyk
Journal:  Med Decis Making       Date:  2016-12-27       Impact factor: 2.583

Review 4.  Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.

Authors:  Keith Humphreys; Chelsea L Shover; Christina M Andrews; Amy S B Bohnert; Margaret L Brandeau; Jonathan P Caulkins; Jonathan H Chen; Mariano-Florentino Cuéllar; Yasmin L Hurd; David N Juurlink; Howard K Koh; Erin E Krebs; Anna Lembke; Sean C Mackey; Lisa Larrimore Ouellette; Brian Suffoletto; Christine Timko
Journal:  Lancet       Date:  2022-02-02       Impact factor: 202.731

5.  Dynamics in the costs of criminality among opioid dependent individuals.

Authors:  Emanuel Krebs; Thomas Kerr; Julio Montaner; Evan Wood; Bohdan Nosyk
Journal:  Drug Alcohol Depend       Date:  2014-09-22       Impact factor: 4.492

6.  Integration of substance use disorder services with primary care: health center surveys and qualitative interviews.

Authors:  Darren Urada; Cheryl Teruya; Lillian Gelberg; Richard Rawson
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-03-28

7.  The effects of participation level on recidivism: a study of drug treatment courts using propensity score matching.

Authors:  Elizabeth J Gifford; Lindsey M Eldred; Sabrina A McCutchan; Frank A Sloan
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-09-24

8.  Alternatives to Arrest for Illicit Opioid Use: A Joint Criminal Justice and Healthcare Treatment Collaboration.

Authors:  Andrea J Yatsco; Rachel D Garza; Tiffany Champagne-Langabeer; James R Langabeer
Journal:  Subst Abuse       Date:  2020-08-31

9.  Health outcomes and cost-effectiveness of diversion programs for low-level drug offenders: A model-based analysis.

Authors:  Cora L Bernard; Isabelle J Rao; Konner K Robison; Margaret L Brandeau
Journal:  PLoS Med       Date:  2020-10-13       Impact factor: 11.069

10.  A qualitative study of big data and the opioid epidemic: recommendations for data governance.

Authors:  Elizabeth A Evans; Elizabeth Delorme; Karl Cyr; Daniel M Goldstein
Journal:  BMC Med Ethics       Date:  2020-10-21       Impact factor: 2.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.